NCT02314182 2025-12-19
GRECCAR8
Hospices Civils de Lyon
Phase 3 Completed
Clinical Trials
77 trialsNCT02921256 2025-12-04
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01804790 2025-06-12
Néofirinox
UNICANCER
Phase 3 Completed
NCT04696757 2025-02-12
NORMANDY
Kangbuk Samsung Hospital
Phase 2 Completed
NCT03916510 2025-02-06
CEDAR
University of Oxford
Phase 1 Completed
NCT02861300 2024-12-19
CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer
Case Comprehensive Cancer Center
Phase 1/2 Completed
NCT04679597 2024-10-17
Total Neoadjuvant Therapy Versus Standard Therapy of Locally Advanced Rectal Cancer With High Risk Factors for Failure
Institute of Oncology Ljubljana
Completed
NCT02514278 2024-08-14
GRECCAR12
University Hospital, Bordeaux
Phase 3 Completed
NCT02528175 2023-12-07
Magnetic Resonance-Guided High Intensity Focused Ultrasound for Recurrent Rectal Cancer
Sunnybrook Health Sciences Centre
Phase NA Completed
NCT02017704 2023-10-17
CORRECT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT02551237 2023-10-13
NACRE
UNICANCER
Phase 3 Completed
NCT00107250 2023-08-04
AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)
Canadian Cancer Trials Group
Phase 1 Completed
NCT03299660 2023-03-16
Avelumab With Chemoradiation in Locally Advanced Rectal Cancer
Peter MacCallum Cancer Centre, Australia
Phase 2 Completed
NCT02935309 2022-05-31
Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT01308190 2021-11-23
Preoperative Chemoradiotherapy and Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in T2-T3s N0, M0 Rectal Cancer
Corporacion Parc Tauli
Phase 3 Completed
NCT03152370 2021-10-04
PRAER 1
Adlai Nortye Biopharma Co., Ltd.
Phase 1 Completed
NCT00070213 2021-09-27
Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
Medical Research Council
Phase 3 Completed
NCT00640081 2021-09-22
Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer
Medical Research Council
Phase 2 Completed
NCT02860234 2021-07-23
Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant Treatment
Peking University Cancer Hospital & Institute
Completed
NCT02864849 2021-07-23
Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal Cancer
Peking University Cancer Hospital & Institute
Phase 2 Completed
NCT02393755 2021-07-08
Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer
Roswell Park Cancer Institute
Phase 1/2 Completed
NCT00104689 2021-02-21
Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer
UNICANCER
Phase 2 Completed
NCT00227747 2021-02-17
Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer
UNICANCER
Phase 3 Completed
NCT00423696 2021-02-17
Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
UNICANCER
Phase 2 Completed
NCT01781403 2021-02-04
Preoperative CRT With Temozolomide Plus Capecitabine in Rectal Cancer
Asan Medical Center
Phase 1 Completed
NCT01224392 2020-12-30
RectumSIB
Universitair Ziekenhuis Brussel
Phase 3 Completed
NCT01500993 2020-11-27
Rektum-III
Universitätsmedizin Mannheim
Phase 3 Completed
NCT02178644 2020-10-08
Pilot Trial of KD018 With Neo-Adjuvant Concurrent Chemo-Radiation Therapy in Patients With Locally Advanced Rectal Cancer
Yale University
Phase 1 Completed
NCT01634685 2020-08-20
A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal Adenocarcinoma
University of Texas Southwestern Medical Center
Phase 1 Completed
NCT01471353 2020-07-23
SorCape
University of Florida
Phase 2 Completed
NCT00081289 2020-02-27
Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer
Radiation Therapy Oncology Group
Phase 2 Completed
NCT00828672 2019-07-10
AXEBEAM
Universitaire Ziekenhuizen KU Leuven
Phase 2 Completed
NCT00004187 2019-06-26
Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
Swiss Cancer Institute
Phase 1/2 Completed
NCT00869570 2019-05-15
External-Beam Radiation Therapy, Capecitabine, and Sorafenib in Treating Patients With Locally Advanced Rectal Cancer
Swiss Cancer Institute
Phase 1/2 Completed
NCT00321685 2019-03-27
Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01310985 2019-03-01
A Trial of Pre-Operative Chemoradiotherapy Using Capecitabine, Radiation & Cetuximab, in Rectal Cancer
King Faisal Specialist Hospital & Research Center
Completed
NCT00613080 2018-09-25
Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer
Radiation Therapy Oncology Group
Phase 2 Completed
NCT00003867 2018-09-10
Irinotecan and Capecitabine in Treating Patients With Solid Tumors
Montefiore Medical Center
Phase 1 Completed
NCT00749450 2018-07-27
Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer
Cancer Research UK, Glasgow
Phase 3 Completed
NCT00686166 2018-05-18
S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer
SWOG Cancer Research Network
Phase 2 Completed
NCT00114231 2018-03-29
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00847119 2017-08-29
xeberecto
Institut Català d'Oncologia
Phase 2 Completed
NCT01273051 2017-04-14
CARTS
Radboud University Medical Center
Phase 2 Completed
NCT01060007 2017-03-08
Five Fractions of Radiotherapy Followed by Full Dose FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer
Washington University School of Medicine
Phase 2 Completed
NCT02694718 2017-01-11
A Study of Capecitabine Plus Oxaliplatin in Combination With Pre-operative Pelvic Radiotherapy in Rectal Cancer
Hoffmann-La Roche
Phase 2 Completed
NCT03015168 2017-01-09
Prognostic Value of Neutrophil-to-lymphocyte Ratio (NLR) on Rectal Cancer Patients
General Hospital of Ningxia Medical University
Completed
NCT01043484 2016-10-19
AVAXEL
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Phase 2 Completed
NCT00766155 2016-10-12
PETACC-6
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00003704 2016-07-06
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
Alliance for Clinical Trials in Oncology
Phase 1 Completed
NCT00022698 2016-04-15
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
Hoffmann-La Roche
Phase 2 Completed